bioRxiv · 10.1101/2023.08.03.551883
Compound activity prediction with dose-dependent transcriptomic profiles and deep learning
Abstract
Predicting compound activity in assays is a long-standing challenge in drug discovery. Computational models based on compound-induced gene-expression signatures from a single profiling assay have shown promise towards predicting compound activity in other, seemingly unrelated, assays. Applications of such models include predicting mechanisms-of-action (MoA) for phenotypic hits, identifying off-target activities, and identifying polypharmacologies. Here, we introduce Transcriptomics-to-Activity Transformer (TAT) models that leverage gene-expression profiles observed over compound treatment at multiple concentrations to predict compound activity in other biochemical or cellular assays. We built TAT models based on gene-expression data from a RASL-Seq assay to predict the activity of 2,692 compounds in 262 dose response assays. We obtained useful models for 51% of the assays as determined through a realistic held-out set. Prospectively, we experimentally validated the activity predictions of a TAT model in a malaria inhibition assay. With a 63% hit rate, TAT successfully identified several sub-micromolar malaria inhibitors. Our results thus demonstrate the potential of transcriptomic responses over compound concentration and the TAT modeling framework as a cost-efficient way to identify the bioactivities of promising compounds across many assays.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Godinez, W. J., Trifonov, V., Fang, B., Kuzu, G., Pei, L., Guiguemde, W. A., Martin, E. J., King, F. J., Jenkins, J. L., Skewes-Cox, P.. 2023-08-06. Compound activity prediction with dose-dependent transcriptomic profiles and deep learning. https://doi.org/10.1101/2023.08.03.551883
Cite the original work for its findings. Save a collection to share your selection of sources.